BNW

B N W: Biafra Nigeria World News

Cure for Diabetes: Akwa Ibom Gives N192m for Clinical Trials From Paul Ibe in Abuja Help is finally on the way for patients of diabetes following Akwa Ibom State government's grant of N192 million to the National Institute of Pharmaceutical Research and Development (NIPRD), Idu for clinical trials of a possible cure for the ailment. THISDAY had reported on May 23, 2003 that a Nigerian scientist, Dr. Louis Obyo Nelson, had been granted a United States patent titled, "Medicament for the Treatment of Diabetes," a feat which has raised hopes for more than 400 million patients of the disease worldwide. It was also reported on June 5 last year that a confirmation from the United States Patent Office had indeed granted been to Nelson with the patent number 6,531,461 for his discovery. Nelson's discovery, which had generated interests at home and abroad, however, suffered from lack of funds for further research until Akwa Ibom State government came to the rescue. It was gathered that the signing ceremony of the grant would take place in Uyo tomorrow between officials of the state government and NIPRD. Dr. Edet Attih, the state Commissioner for Health, confirmed to THISDAY on telephone yesterday of the state government's grant to NIPRD for clinical trials of the compounds identified by Nelson's that may pose a possible cure for diabetes. Unlike insulin, which has been used for many decades to manage diabetes, Nelson's discovery can be administered orally, making it possible for patients to administer it as capsule, tablet or syrup. Insulin can only be injected into the body. Another feature of the Nelson's discovery is that instead of merely "managing" the situation like insulin does, it offers "remission" of the condition to the point that it is possible to have a diabetic completely treated. The award of a US patent to Nelson, a graduate of Chemistry from the University of Ibadan, was made on the strength of his research, which determined the exact chemical structure of the active ingredient. The research was also able to determine the quantity of the drug, which could be tolerated in the human body, and yet is able to stem the patient's condition. Who Are We ? | About THISDAYOnLine.com | THISDAY People | Contact Us © Copyright 2000 Leaders & Company Limited

	BNW News
Voice of Biafra | Biafra World | Biafra Online | Biafra Web | MASSOB | Biafra Forum | BLM | Biafra Consortium
	© 2001 BNW BiafraNigeriaWorld  Privacy Policy ---------------------------------------------------------------------------------- Powered by ACENetwork ----------------------------------------------------------------------------------
	Axiom PSI Yam Festival Series, Iri Ji Nd'Igbo the Kola-Nut Series,Nigeria Masterweb